Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.763
+0.123 (19.27%)
Nov 5, 2024, 3:48 PM EST - Market open

Athira Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Net Income
-113.45-117.67-95.64-54.85-19.96-5.16
Upgrade
Depreciation & Amortization
0.970.970.850.4800
Upgrade
Other Amortization
-----0.26
Upgrade
Loss (Gain) From Sale of Investments
-1.11-1.41-0.420.490.25-
Upgrade
Stock-Based Compensation
10.6110.6210.614.620.630.25
Upgrade
Other Operating Activities
0.230.210.20.161.40.26
Upgrade
Change in Accounts Receivable
-1.231.11-1.04-1.3-0.02
Upgrade
Change in Accounts Payable
5.27.372.15.152.60.7
Upgrade
Change in Unearned Revenue
-----1.5-
Upgrade
Change in Other Net Operating Assets
-0.86-2.078.731.89-6.25-
Upgrade
Operating Cash Flow
-98.41-100.75-72.47-43.1-24.11-3.71
Upgrade
Capital Expenditures
-0.06-0.3-1.14-1.57-2.32-
Upgrade
Investment in Securities
66.7595.3958.81-2.51-207.781.5
Upgrade
Other Investing Activities
----0.040.01
Upgrade
Investing Cash Flow
66.6895.0957.66-4.08-210.071.51
Upgrade
Long-Term Debt Issued
----1.660.87
Upgrade
Net Debt Issued (Repaid)
----1.660.87
Upgrade
Issuance of Common Stock
0.30.490.6597.09209.160.07
Upgrade
Financing Cash Flow
0.30.490.6597.09292.750.95
Upgrade
Net Cash Flow
-31.43-5.17-14.1549.9158.57-1.26
Upgrade
Free Cash Flow
-98.47-101.06-73.61-44.67-26.43-3.71
Upgrade
Free Cash Flow Per Share
-2.58-2.66-1.95-1.21-2.21-1.04
Upgrade
Levered Free Cash Flow
-68.05-60.9-36.5-31.15-18.95-2.43
Upgrade
Unlevered Free Cash Flow
-68.05-60.9-36.5-31.15-18.72-2.47
Upgrade
Change in Net Working Capital
3.7-7.25-11.95-5.344.54-0.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.